Sunday, June 26, 2022

BioSig Technologies Inc. [BSGM] Chief Executive Officer makes an insider purchase of 9,300 shares worth 10695.0.

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. BioSig Technologies Inc. shares valued at $10,695 were purchased by LONDONER KENNETH L on May 25. At $1.15 per share, LONDONER KENNETH L acquired 9,300 shares. The insider’s holdings grew to 1,712,788 shares worth approximately $1.71 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Also, LONDONER KENNETH L purchased 8,744 shares, netting a total of over 9,601 in proceeds. Following the buying of shares at $1.10 each, the insider now holds 1,703,488 shares.

Before that, LONDONER KENNETH L had added 11,850 shares to its account. In a trade valued at $13,539, the Chief Executive Officer bought BioSig Technologies Inc. shares for $1.14 each. Upon closing the transaction, the insider’s holdings increased to 11,850 shares, worth approximately $1.69 million.

As published in their initiating research note from ROTH Capital on March 30, 2020, BioSig Technologies Inc. [BSGM] has been a Buy and the price target has been revised to $9. This represents a 88.89% premium over Thursday’s closing price.

Analyzing BSGM’s Price Performance

On Thursday, BioSig Technologies Inc. [NASDAQ: BSGM] rose 13.64% to $1.00. The stock’s lowest price that day was $0.9682, but it reached a high of $1.25 in the same session. During the last five days, there has been a surge of approximately 33.33%. Over the course of the year, BioSig Technologies Inc. shares have dropped approximately -55.16%. Shares of the company reached a 52-week high of $2.4600 on 01/05/22 and a 52-week low of $0.6300 on 06/16/22. A 50-day SMA is recorded $0.9418, while a 200-day SMA reached $1.8962. Nevertheless, trading volume fell to 1.51 million shares from 0.24 million shares the previous day.

Support And Resistance Levels for BioSig Technologies Inc. (BSGM)

According to the 24-hour chart, there is a support level at 0.8955, which, if violated, would cause prices to drop to 0.7909. In the upper region, resistance lies at 1.1773. The next price resistance is at 1.3545. RSI (Relative Strength Index) is 56.86 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0415, which suggests the price will decrease in the coming days. Percent R is at 40.32%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Is BioSig Technologies Inc. subject to short interest?

Stocks of BioSig Technologies Inc. saw a sharp rise in short interest on May 30, 2022 jumping by 0.31 million shares to 2.26 million. Data from Yahoo Finance shows that the short interest on Apr 28, 2022 was 1.95 million shares. A jump of 13.72% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.42 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.42.

Which companies own the most shares of BioSig Technologies Inc. (BSGM)?

According to The Vanguard Group, Inc. filings, the company currently owns 1,084,728 shares, which is about 2.74% of the total BSGM shares outstanding. The investor’s shares have plunged by -209,938 from its previous 13-F filing of 1294666.0 shares. With the completion of the buy transaction, InterOcean Capital Group LLC’s stake is now worth $881,391. BlackRock Fund Advisors reduced a -0.69% interest valued at $0.51 million while Cambridge Investment Research Adv purchased a 83,600 stake. A total of -1 shares of BioSig Technologies Inc. were bought by Geode Capital Management LLC during the quarter, and 250 were bought by Smith, Moore & Co. In its current portfolio, Zeke Capital Advisors LLC holds 156,243 shares valued at $0.15 million.

In terms of BioSig Technologies Inc. share price expectations, FactSet research, analysts set an average price target of $5.00 in the next 12 months, up nearly 468.18% from the previous closing price of $0.88. Analysts anticipate BioSig Technologies Inc. stock to reach $6.00 by 2022, with the lowest price target being $4.00. In spite of this, 2 analysts ranked BioSig Technologies Inc. stock as a Buy at the end of 2022.

Latest news

Related news


Please enter your comment!
Please enter your name here




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam